Literature DB >> 11950706

Elevated soluble cellular adhesion molecules in subjects with low HDL-cholesterol.

Laura Calabresi1, Monica Gomaraschi, Barbara Villa, Laura Omoboni, Camille Dmitrieff, Guido Franceschini.   

Abstract

The purpose of this study was to investigate whether the expression of cellular adhesion molecules (CAMs) is enhanced in individuals with low HDL cholesterol (HDL-C). Plasma levels of soluble vascular cell adhesion molecule-1 (sVCAM-1), intercellular adhesion molecule-1 (sICAM-1), and E-selectin (sE-selectin) were measured in subjects with low (below the 10th percentile for the Italian population), average, or high (above the 90th percentile) HDL-C. Average sICAM-1 and sE-selectin levels were significantly higher in two groups of 65 individuals with low HDL levels, either hyperlipidemic (320.5+/-16.0 and 61.4+/-3.5 ng/mL) or normolipidemic (309.6+/-13.0 and 60.0+/-2.7 ng/mL), than in subjects with average HDL levels, either hyperlipidemic (267.0+/-10.1 and 50.4+/-2.8 ng/mL) or normolipidemic (257.9+/-5.4 and 51.1+/-2.4 ng/mL), or with high HDL levels (254.8+/-10.2 and 52.5+/-3.2 ng/mL). No significant difference was found in the plasma sVCAM-1 concentration. HDL-C was inversely correlated with sICAM-1 and sE-selectin in the low-HDL subjects (r(2)=0.087 and 0.035, P=0.0007 and 0.033, respectively), but not in individuals with normal or elevated HDL-C (r(2)=0.012 and 0.006). A fenofibrate-induced increase of HDL-C in 20 low-HDL subjects was associated with a significant reduction of plasma sICAM-1 and sE-selectin concentrations. An increased CAMs expression may be a mechanism by which a low plasma HDL level promotes atherogenesis and causes acute atherothrombotic events.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11950706     DOI: 10.1161/hq0402.105901

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  23 in total

Review 1.  New insights into the role of HDL as an anti-inflammatory agent in the prevention of cardiovascular disease.

Authors:  Philip J Barter; Rajesh Puranik; Kerry-Anne Rye
Journal:  Curr Cardiol Rep       Date:  2007-11       Impact factor: 2.931

Review 2.  Evolving concepts of the role of high-density lipoprotein in protection from atherosclerosis.

Authors:  John A Farmer; Joshua Liao
Journal:  Curr Atheroscler Rep       Date:  2011-04       Impact factor: 5.113

3.  Low high-density lipoprotein cholesterol and particle concentrations are associated with greater levels of endothelial activation markers in Multi-Ethnic Study of Atherosclerosis participants.

Authors:  Brian T Steffen; Suzette J Bielinski; Paul A Decker; Cecilia Berardi; Nicholas B Larson; James S Pankow; Erin D Michos; Naomi Q Hanson; David M Herrington; Michael Y Tsai
Journal:  J Clin Lipidol       Date:  2017-06-13       Impact factor: 4.766

4.  Adiposity is associated with endothelial activation in healthy 2-3 year-old children.

Authors:  Cecilia Castro; Russell P Tracy; Richard J Deckelbaum; Charles E Basch; Steven Shea
Journal:  J Pediatr Endocrinol Metab       Date:  2009-10       Impact factor: 1.634

5.  Association of E-selectin gene polymorphism and serum PAPP-A with carotid atherosclerosis in end-stage renal disease.

Authors:  Marianne Samir M Issac; Alaa Afif; Nadida A Gohar; Nahla A Fawzy Fayek; Bahaa Zayed; Heba Sedrak; Lamiaa Adel Salah El Din
Journal:  Mol Diagn Ther       Date:  2014-04       Impact factor: 4.074

Review 6.  Fibrate therapy in patients with metabolic syndrome and diabetes mellitus.

Authors:  Thomas Dayspring; Gregory Pokrywka
Journal:  Curr Atheroscler Rep       Date:  2006-09       Impact factor: 5.113

7.  Insulin resistance is associated with at least threefold increased risk for prothrombotic state in severely obese youngsters.

Authors:  Assimina Galli-Tsinopoulou; Ioannis Kyrgios; Ioanna Maggana; Eleni Z Giannopoulou; Eleni P Kotanidou; Charilaos Stylianou; Emmanouil Papadakis; Ioannis Korantzis; George Varlamis
Journal:  Eur J Pediatr       Date:  2010-12-08       Impact factor: 3.183

8.  Depletion in LpA-I:A-II particles enhances HDL-mediated endothelial protection in familial LCAT deficiency.

Authors:  Monica Gomaraschi; Alice Ossoli; Samuela Castelnuovo; Sara Simonelli; Chiara Pavanello; Gloria Balzarotti; Marcello Arca; Alessia Di Costanzo; Tiziana Sampietro; Gaetano Vaudo; Damiano Baldassarre; Fabrizio Veglia; Guido Franceschini; Laura Calabresi
Journal:  J Lipid Res       Date:  2017-03-28       Impact factor: 5.922

9.  High-density lipoproteins are a potential therapeutic target for age-related macular degeneration.

Authors:  Una L Kelly; Daniel Grigsby; Martha A Cady; Michael Landowski; Nikolai P Skiba; Jian Liu; Alan T Remaley; Mikael Klingeborn; Catherine Bowes Rickman
Journal:  J Biol Chem       Date:  2020-07-31       Impact factor: 5.157

Review 10.  Role of fibric acid derivatives in the management of risk factors for coronary heart disease.

Authors:  Jean-Pierre Després; Isabelle Lemieux; Sander J Robins
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.